Comment évaluer le risque oncologique d'un patient souffrant de dermatomyosite [Can we predict the risk of malignancy associated with dermatomyositis?]

Détails

ID Serval
serval:BIB_0FF609A29505
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Comment évaluer le risque oncologique d'un patient souffrant de dermatomyosite [Can we predict the risk of malignancy associated with dermatomyositis?]
Périodique
Praxis
Auteur⸱e⸱s
Gainon J., Bart P.A., Waeber G.
ISSN
1661-8157
Statut éditorial
Publié
Date de publication
2003
Volume
92
Numéro
41
Pages
1734-9
Langue
français
Notes
Publication types: Case Reports ; Comparative Study ; English Abstract ; Journal Article - Publication Status: ppublish
Résumé
Dermatomyositis (DM) and polymyositis (PM) are idiopathic inflammatory muscle diseases which remain a therapeutic challenge. The association between DM and malignancy is relatively well established while this relationship is weaker with PM. The clinical management and research for an occult malignancy as well as the follow-up of patients with DM or PM is a matter of debate. Herein we report a case of DM who, despite an extensive clinical, radiological and biological work-up developed an occult ovarian cancer 12 months after the initial diagnosis. This case report was used as support to review the actual expert recommendations for the search of an occult malignancy in presence of DM or PM.
Mots-clé
Adenocarcinoma, Aged, Anti-Inflammatory Agents, Anti-Inflammatory Agents, Non-Steroidal, Azathioprine, Cyclosporins, Dermatologic Agents, Dermatomyositis, Diagnosis, Differential, Female, Glucocorticoids, Humans, Immunosuppressive Agents, Mycophenolic Acid, Ovarian Neoplasms, Polymyositis, Prednisone, Risk Factors, Time Factors
Pubmed
Création de la notice
25/01/2008 15:10
Dernière modification de la notice
20/08/2019 13:36
Données d'usage